Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
44
SBMFF Quote, Financials, Valuation and Earnings
Last price:
$0.87
Seasonality move
:
-3.14%
Day range:
$0.87 - $0.87
52-week range:
$0.37 - $1.24
Dividend yield:
1.32%
P/E ratio:
30.49x
P/S ratio:
3.70x
P/B ratio:
4.10x
Volume:
--
Avg. volume:
13
1-year change:
112.04%
Market cap:
$15.6B
Revenue:
$4B
EPS (TTM):
$0.03
Earnings Data
Next earnings date for SBMFF
Mar 19
2026
Most recent earnings per share
$0.01
Beat by $0.01
(Mar 23/2021)
Consensus Estimate
--
(Mar 23/2021)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SBMFF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/23/2021 | Q4 | -- | -- | $0.01 | -- | -- |
| 11/30/2020 | Q3 | -- | -- | $0.00 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | $0.00 | -- | -- |
| 04/21/2020 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.00 | -- | -- |
| 11/26/2019 | Q3 | -- | -- | $0.01 | -- | -- |
| 09/27/2019 | Q2 | -- | -- | $0.00 | -- | -- |
| 05/21/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.05 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.01 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | $0.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | $0.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.00 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.00 | -- | -- |
Sino Biopharmaceutical Ltd. Earnings Questions
-
How Much did Sino Biopharmaceutical Ltd. Generate in Revenue Last Quarter?
Sino Biopharmaceutical Ltd. reported -- worth of top line sales in its most recent quarter.
-
Did Sino Biopharmaceutical Ltd. Beat Earnings Last Quarter?
Sino Biopharmaceutical Ltd. announced earnings per share of $0.01 which represents a beat of analyst forecast a -- per share.
-
Is Sino Biopharmaceutical Ltd. Profitable?
Sino Biopharmaceutical Ltd. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sino Biopharmaceutical Ltd. EPS Next Year?
Sino Biopharmaceutical Ltd.'s earnings are forecast to grow from $0.01 per share to -- per share next year representing an increase of --.
-
When is Sino Biopharmaceutical Ltd.'s Earnings Date?
Sino Biopharmaceutical Ltd.'s next earnings date is March 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
